Redox signaling, Nox5 and vascular remodeling in hypertension
Authors:
- Sofia TsiropoulouSTSofia Tsiropoulou
- Maria Dulak-LisMDMaria Dulak-Lis
- Adam HarveyAHAdam Harvey
- Livia De Lucca CamargoLCLivia De Lucca Camargo
- Rhian M. TouyzRTRhian M. Touyz
Open Access
- 1 September 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 24 (5) , 425-433
Abstract
Extensive data indicate a role for reactive oxygen species (ROS) and redox signaling in vascular damage in hypertension. However, molecular mechanisms underlying these processes remain unclear, but oxidative post-translational modification of vascular proteins is critical. This review discusses how proteins are oxidatively modified and how redox signaling influences vascular smooth muscle cell growth and vascular remodeling in hypertension. We also highlight Nox5 as a novel vascular ROS-generating oxidase. Oxidative stress in hypertension leads to oxidative imbalance that affects vascular cell function through redox signaling. Many Nox isoforms produce ROS in the vascular wall, and recent findings show that Nox5 may be important in humans. ROS regulate signaling by numerous processes including cysteine oxidative post-translational modification such as S-nitrosylation, S-glutathionylation and sulfydration. In vascular smooth muscle cells, this influences cellular responses to oxidative stimuli promoting changes from a contractile to a proliferative phenotype. In hypertension, Nox-induced ROS production is increased, leading to perturbed redox signaling through oxidative modifications of vascular proteins. This influences mitogenic signaling and cell cycle regulation, leading to altered cell growth and vascular remodeling in hypertension.Keywords
This publication has 92 references indexed in Scilit:
- Oxidative Stress and Antioxidants in Hypertension–A Current ReviewCurrent Hypertension Reviews, 2015
- The cysteine proteomeFree Radical Biology and Medicine, 2015
- Reactive oxygen species and redox compartmentalizationFrontiers in Physiology, 2014
- Inhibition of NOX/VPO1 Pathway and Inflammatory Reaction by Trimethoxystilbene in Prevention of Cardiovascular Remodeling in Hypoxia-induced Pulmonary Hypertensive RatsJournal of Cardiovascular Pharmacology, 2014
- MicroRNA‐365 Inhibits the Proliferation of Vascular Smooth Muscle Cells by Targeting Cyclin D1Journal of Cellular Biochemistry, 2014
- Angiotensin II and Vascular InjuryCurrent Hypertension Reports, 2014
- Nitric oxide reduces NADPH oxidase 5 (Nox5) activity by reversible S-nitrosylationFree Radical Biology and Medicine, 2012
- Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHRJournal of the American Society of Hypertension, 2011
- Redox Signaling, Vascular Function, and HypertensionAntioxidants & Redox Signaling, 2008
- The actin cytoskeleton response to oxidants: from small heat shock protein phosphorylation to changes in the redox state of actin itselfFree Radical Biology and Medicine, 2001